Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Breast Neoplasms × Probiotics × Clear all

Phase

Phase NA 4 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 1 Cancer Therapy-related Cardiovascular Toxicity 1 Breast Neoplasms 1

Interventions

Letrozole 16 Docetaxel 11 Anastrozole 11 exemestane 10 Cyclophosphamide 9 Zoledronic Acid 8 Tamoxifen 8 Trastuzumab 7 Paclitaxel 7 Capecitabine 7 pegfilgrastim 6 Saline Solution 6 Fulvestrant 6 liposomal doxorubicin 5 Dexmedetomidine 5 Bupivacaine 5 Bevacizumab 5 Tranexamic Acid 4 Sodium Chloride 4 Filgrastim 4 Epirubicin 4 trastuzumab deruxtecan 3 technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 3 ribociclib 3 pertuzumab 3 palbociclib 3 eribulin 3 abemaciclib 3 Standard of Care 3 Sevoflurane 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05562518 2025-07-23

GRACE

University Hospital, Ghent

Phase 4 Recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡